Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction
暂无分享,去创建一个
F. Fedele | C. Lavalle | M. Mancone | F. Infusino | W. Chilian | V. Maestrini | P. Severino | A. D’Amato | F. Adamo | M. Pucci | L. Birtolo | L. Netti | G. Montefusco | C. Chimenti | Mariateresa Pucci | Lucrezia Netti
[1] F. Fedele,et al. Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak , 2020, ESC heart failure.
[2] F. Fedele,et al. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis , 2020, Journal of Thrombosis and Thrombolysis.
[3] Deepak L. Bhatt,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.
[4] Coronavirus disease 2019 in Rome: was it circulating before December? , 2020, Journal of cardiovascular medicine.
[5] F. Fedele,et al. The role of cardiologists in the coronavirus disease 2019 pandemic. , 2020, Kardiologia polska.
[6] C. Weber,et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science , 2020, Cardiovascular research.
[7] F. Fedele,et al. Left ventricular wall stress is associated with myocardial functional recovery in patients with severe aortic stenosis and systolic dysfunction undergoing transcatheter aortic valve replacement , 2020, Journal of cardiovascular medicine.
[8] A. Baumbach,et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] F. Fedele,et al. The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization , 2020, Journal of clinical medicine.
[10] F. Fedele,et al. Management of cardiac implantable electronic device follow‐up in COVID‐19 pandemic: Lessons learned during Italian lockdown , 2020, Journal of cardiovascular electrophysiology.
[11] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[12] J. Rodríguez-Peralto,et al. SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases , 2020, The British journal of dermatology.
[13] M. Bifulco,et al. Statin therapy in COVID-19 infection: much more than a single pathway , 2020, European heart journal. Cardiovascular pharmacotherapy.
[14] F. Fedele,et al. Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors. , 2020, European journal of preventive cardiology.
[15] F. Fedele,et al. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review , 2020, Nutrients.
[16] P. Ponikowski,et al. Management of heart failure patients with COVID‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.
[17] Axel Haverich,et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.
[18] S. Solomon,et al. COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease , 2020, European journal of heart failure.
[19] Angelo Mazza,et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.
[20] P. Theocharis,et al. Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.
[21] F. Gao,et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 , 2020, Science.
[22] K. Mertz,et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.
[23] F. Fedele,et al. Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels , 2020, International journal of molecular sciences.
[24] F. Crea,et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options , 2020, Cardiovascular research.
[25] Michele Emdin,et al. Statin therapy in COVID-19 infection , 2020, European heart journal. Cardiovascular pharmacotherapy.
[26] R. Bonow,et al. Myocardial ischemia: From disease to syndrome. , 2020, International journal of cardiology.
[27] E. Kenigsberg,et al. Advancing scientific knowledge in times of pandemics , 2020, Nature Reviews Immunology.
[28] M. Drazner,et al. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome , 2020, Circulation.
[29] G. Lippi,et al. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019 , 2020, Mayo Clinic Proceedings.
[30] Jiagao Lv,et al. Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, Journal of the American Heart Association.
[31] Dong Men,et al. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients , 2020, medRxiv.
[32] D. Tousoulis,et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'. , 2020, Cardiovascular research.
[33] G. Niccoli,et al. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019 , 2020, European cardiology.
[34] E. Prescott,et al. Diagnosis of coronary microvascular dysfunction in the clinic. , 2020, Cardiovascular research.
[35] C. Gaudio,et al. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. , 2020, European heart journal.
[36] C. Spadaccio,et al. Changes of the coronary arteries and cardiac microvasculature with aging: Implications for translational research and clinical practice , 2019, Mechanisms of Ageing and Development.
[37] F. Fedele,et al. Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist , 2019, Diagnostics.
[38] F. Fedele,et al. Electrocardiographic features, mapping and ablation of idiopathic outflow tract ventricular arrhythmias , 2019, Journal of Interventional Cardiac Electrophysiology.
[39] E. Levelt,et al. Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date , 2019, World journal of diabetes.
[40] G. Heusch. Coronary microvascular obstruction: the new frontier in cardioprotection , 2019, Basic Research in Cardiology.
[41] C. Rapezzi,et al. Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy. , 2019, International journal of cardiology.
[42] O. Delelis,et al. Interplay between Intrinsic and Innate Immunity during HIV Infection , 2019, Cells.
[43] P. Errante,et al. Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection , 2019, International journal of molecular sciences.
[44] F. Fedele,et al. Futility in cardiology: the need for a change in perspectives , 2019, European journal of heart failure.
[45] F. Fedele,et al. Structural and myocardial dysfunction in heart failure beyond ejection fraction , 2019, Heart Failure Reviews.
[46] A. LeBlanc,et al. Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats. , 2019, Journal of visualized experiments : JoVE.
[47] Xiao-Ming Gao,et al. Relaxin mitigates microvascular damage and inflammation following cardiac ischemia–reperfusion , 2019, Basic Research in Cardiology.
[48] D. Waters,et al. HIV infection and coronary heart disease: mechanisms and management , 2019, Nature Reviews Cardiology.
[49] F. Fedele,et al. Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency , 2019, Cardiology research and practice.
[50] D. Hausenloy,et al. Role of Macrophages in Cardioprotection , 2019, International journal of molecular sciences.
[51] R. Korthuis,et al. Reactive species-induced microvascular dysfunction in ischemia/reperfusion. , 2019, Free radical biology & medicine.
[52] H. Jneid,et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association , 2019, Circulation.
[53] F. Fedele,et al. Myocardial Ischemia and Diabetes Mellitus: Role of Oxidative Stress in the Connection between Cardiac Metabolism and Coronary Blood Flow , 2019, Journal of diabetes research.
[54] A. Henning,et al. Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy , 2019, Circulation.
[55] C. Ballantyne,et al. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol , 2019, The New England journal of medicine.
[56] F. Fedele,et al. Triggers for Atrial Fibrillation: The Role of Anxiety , 2019, Cardiology research and practice.
[57] H. Bøtker,et al. Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.
[58] Chi‐Hang Lee,et al. Platelet inhibition to target reperfusion injury trial: Rationale and study design , 2019, Clinical cardiology.
[59] H. Gewirtz. Coronary circulation: Pressure/flow parameters for assessment of ischemic heart disease , 2019, Journal of Nuclear Cardiology.
[60] K. Kinzler,et al. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome , 2018, Nature.
[61] M. Sabatine. PCSK9 inhibitors: clinical evidence and implementation , 2018, Nature Reviews Cardiology.
[62] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[63] Richard D Moore,et al. Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low‐Density Lipoprotein Cholesterol , 2018, Journal of the American Heart Association.
[64] R. Kloner,et al. No-reflow phenomenon in the heart and brain. , 2018, American journal of physiology. Heart and circulatory physiology.
[65] C. Berry,et al. Systemic microvascular dysfunction in microvascular and vasospastic angina , 2018, European heart journal.
[66] Y. Park,et al. Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes , 2018, Cardiovascular Diabetology.
[67] F. Fedele,et al. Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study. , 2018, Atherosclerosis.
[68] X. Tu,et al. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy , 2018, Acta Pharmacologica Sinica.
[69] R. Rosenson,et al. Systematic Review of Methods Used for the Microvascular Assessment of Peripheral Arterial Disease , 2018, Cardiovascular Drugs and Therapy.
[70] G. Heusch,et al. Coronary microembolization and microvascular dysfunction. , 2018, International journal of cardiology.
[71] Sanjiv J. Shah,et al. Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection , 2018, Circulation. Heart failure.
[72] Maria Laura De Marchis,et al. Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels , 2018, International journal of molecular sciences.
[73] A. Koller,et al. Remodeling of Wall Mechanics and the Myogenic Mechanism of Rat Intramural Coronary Arterioles in Response to a Short-Term Daily Exercise Program: Role of Endothelial Factors , 2018, Journal of Vascular Research.
[74] C. Pepine,et al. Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease) , 2018, Clinical cardiology.
[75] S. David,et al. Frequency of Cholesterol Crystals in Culprit Coronary Artery Aspirate During Acute Myocardial Infarction and Their Relation to Inflammation and Myocardial Injury. , 2017, The American journal of cardiology.
[76] T. Marwick,et al. The ageing heart: the systemic and coronary circulation , 2017, Heart.
[77] Andrew S. Holmes,et al. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]) , 2017, Circulation.
[78] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[79] Dana K Dawson,et al. Acute stress-induced (takotsubo) cardiomyopathy , 2017, Heart.
[80] F. Crea,et al. Pathophysiology of Takotsubo Syndrome , 2017, Circulation.
[81] Xiao-Ming Gao,et al. Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry, and magnetic resonance imaging. , 2017, American journal of physiology. Heart and circulatory physiology.
[82] R. Virmani,et al. Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus. , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[83] I. Drenjančević,et al. Coronary microvascular dysfunction in diabetes mellitus , 2017, The Journal of international medical research.
[84] F. Fedele,et al. Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction , 2016, Cardiology in review.
[85] T-cell Activation and E-selectin Are Associated With Coronary Plaque in HIV-infected Young Adults , 2017, The Pediatric infectious disease journal.
[86] J. Moon,et al. Update on hypertrophic cardiomyopathy and a guide to the guidelines , 2016, Nature Reviews Cardiology.
[87] K. Anastos,et al. Trends in Cardiovascular Disease Mortality Among Persons With HIV in New York City, 2001-2012. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[88] W. Shen,et al. Association of decreased serum vasostatin-2 level with ischemic chronic heart failure and with MACE in 3-year follow-up: Vasostatin-2 prevents heart failure in myocardial infarction rats. , 2016, International journal of cardiology.
[89] Qiuyue Kong,et al. HSPA12B Attenuated Acute Myocardial Ischemia/reperfusion Injury via Maintaining Endothelial Integrity in a PI3K/Akt/mTOR-dependent Mechanism , 2016, Scientific Reports.
[90] Xiao-hua Wang,et al. Relationship between platelet-leukocyte aggregation and myocardial perfusion in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. , 2016, Heart & lung : the journal of critical care.
[91] M. Bukrinsky,et al. Interaction Between HIV-1 Nef and Calnexin: From Modeling to Small Molecule Inhibitors Reversing HIV-Induced Lipid Accumulation , 2016, Arteriosclerosis, Thrombosis and Vascular Biology.
[92] R. Kanďár,et al. Fatty acid profile in erythrocyte membranes and plasma phospholipids affects significantly the extent of inflammatory response to coronary stent implantation. , 2016, Physiological research.
[93] C. Gleissner,et al. Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology. , 2016, Atherosclerosis.
[94] H. Niessen,et al. Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction , 2016, PloS one.
[95] E. Bruckert,et al. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature. , 2016, Clinical therapeutics.
[96] Morten Wang Fagerland,et al. Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction , 2016, Journal of the American Heart Association.
[97] R. Feldman. Heart Disease in Women: Unappreciated Challenges, GPER as a New Target , 2016, International journal of molecular sciences.
[98] M. Grant,et al. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. , 2016, Circulation research.
[99] G. Niccoli,et al. Coronary microvascular obstruction in acute myocardial infarction. , 2016, European heart journal.
[100] N. Nader,et al. Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality , 2016, Journal of cardiovascular and thoracic research.
[101] M. Freiberg,et al. HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan , 2016, Journal of the American Heart Association.
[102] S. Grinspoon,et al. Pathophysiology and Management of Cardiovascular Disease in HIV-Infected Patients , 2016, The lancet. Diabetes & endocrinology.
[103] A. Pries,et al. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. , 2015, European heart journal.
[104] M. Nieminen,et al. Pharmaco-economics of levosimendan in cardiology: a European perspective. , 2015, International journal of cardiology.
[105] J. Mehta,et al. LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. , 2015, Biochemical and biophysical research communications.
[106] S. Y-Hassan. Post-ischemic myocardial stunning was the starting point of takotsubo syndrome: Restitution is justified after falling down on. , 2015, International journal of cardiology.
[107] P. Kuppusamy,et al. Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation. , 2015, Circulation research.
[108] J. Mehta,et al. Cross-talk between LOX-1 and PCSK9 in vascular tissues. , 2015, Cardiovascular research.
[109] M. Clauss,et al. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[110] H. Shimokawa,et al. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[111] F. Crea,et al. Sex differences in mechanisms, presentation and management of ischaemic heart disease. , 2015, Atherosclerosis.
[112] F. Romeo,et al. Oxidized LDL attenuates protective autophagy and induces apoptotic cell death of endothelial cells: Role of oxidative stress and LOX-1 receptor expression. , 2015, International journal of cardiology.
[113] F. Fedele,et al. PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROME IN HIV POSITIVE PATIENTS: INSIGHT FROM VIRTUAL HISTOLOGY ANALYSIS , 2015 .
[114] J. Canty,et al. Regulation of coronary blood flow in health and ischemic heart disease. , 2015, Progress in cardiovascular diseases.
[115] Yan Zhang,et al. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. , 2015, American journal of physiology. Heart and circulatory physiology.
[116] F. Fedele,et al. Intramyocardial Hemorrhage: An Enigma for Cardiac MRI? , 2015, BioMed research international.
[117] P. Camici,et al. The role of T and B cells in human atherosclerosis and atherothrombosis , 2015, Clinical and experimental immunology.
[118] Ornella Rimoldi,et al. Coronary microvascular dysfunction: mechanisms and functional assessment , 2015, Nature Reviews Cardiology.
[119] N. Wu,et al. Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart. , 2014, Molecular medicine reports.
[120] J. DiNicolantonio,et al. Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. , 2014, Thrombosis research.
[121] L. Hurley,et al. HIV infection and incidence of ischemic stroke , 2014, AIDS.
[122] H. White,et al. Prognosis of Patients With Non–ST-Segment–Elevation Myocardial Infarction and Nonobstructive Coronary Artery Disease: Propensity-Matched Analysis From the Acute Catheterization and Urgent Intervention Triage Strategy Trial , 2014, Circulation. Cardiovascular interventions.
[123] F. Fedele,et al. Heart failure: TNM-like classification. , 2014, Journal of the American College of Cardiology.
[124] F. Crea,et al. Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .
[125] H. Bøtker,et al. The role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart disease , 2014, Basic Research in Cardiology.
[126] Christopher J. L. Murray,et al. Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010: The Global Burden of Disease 2010 Study , 2013, Circulation.
[127] P. Fülöp,et al. Dynamic interplay between metabolic syndrome and immunity. , 2014, Advances in experimental medicine and biology.
[128] F. Fedele,et al. Role of ion channels in coronary microcirculation: a review of the literature. , 2013, Future cardiology.
[129] J. Frostegård. Immune Mechanisms in Atherosclerosis, Especially in Diabetes Type 2 , 2013, Front. Endocrinol..
[130] F. Fedele,et al. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease , 2013, Basic Research in Cardiology.
[131] W. Koch,et al. Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy , 2013, Circulation research.
[132] D. Schwenke,et al. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation , 2013, Cardiovascular Diabetology.
[133] P. Camici,et al. Coronary microvascular dysfunction in primary cardiomyopathies , 2013, Heart.
[134] V. Ortiz de la Tabla,et al. Increased Carotid Intima-Media Thickness Associated with Antibody Responses to Varicella-Zoster Virus and Cytomegalovirus in HIV-Infected Patients , 2013, PloS one.
[135] M. Budoff,et al. HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.
[136] Randall C. Thompson,et al. Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations , 2013, The Lancet.
[137] Jeffrey A. Jones,et al. Gene targeting in ischemic heart disease and failure: translational and clinical studies. , 2013, Biochemical pharmacology.
[138] R. Bonow,et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! , 2012, Journal of the American College of Cardiology.
[139] E. Jones,et al. Cardiac syndrome X and microvascular coronary dysfunction. , 2012, Trends in cardiovascular medicine.
[140] S. Abbara,et al. Arterial inflammation in patients with HIV. , 2012, JAMA.
[141] Jeffrey N. Martin,et al. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease , 2012, AIDS.
[142] O. Rimoldi,et al. The coronary circulation and blood flow in left ventricular hypertrophy. , 2012, Journal of molecular and cellular cardiology.
[143] Mark Woodward,et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies , 2012 .
[144] C. Cametti,et al. Hemocompatibility of stent materials: alterations in electrical parameters of erythrocyte membranes , 2012, Vascular health and risk management.
[145] A. Huqi,et al. Coronary vasospasm and coronary atherosclerosis: do we have to choose? , 2012, Journal of the American College of Cardiology.
[146] Jeroen J. Bax,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .
[147] R. Blankstein,et al. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. , 2011, Journal of the American College of Cardiology.
[148] Andrés Íñiguez,et al. Modulación del sistema betaadrenérgico durante el infarto agudo de miocardio: justificación para un nuevo ensayo clínico , 2011 .
[149] L. Kuller,et al. Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. , 2011, Archives of internal medicine.
[150] J. Hochman,et al. Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: an autopsy study. , 2011, American heart journal.
[151] F. Fedele,et al. Cardiovascular risk factors and HIV disease. , 2011, AIDS reviews.
[152] L. Lerman,et al. Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. , 2011, American journal of physiology. Heart and circulatory physiology.
[153] [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial]. , 2011, Revista espanola de cardiologia.
[154] W. Chilian,et al. Corruption of coronary collateral growth in metabolic syndrome: Role of oxidative stress. , 2010, World journal of cardiology.
[155] M. Russo,et al. High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: comparison with chronic stable angina and normal controls , 2010, Heart.
[156] Carl J Pepine,et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, Journal of the American College of Cardiology.
[157] A. Rebuzzi,et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome. , 2010, European heart journal.
[158] Chi‐Hang Lee,et al. Microvascular obstruction after percutaneous coronary intervention , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[159] C. Catalano,et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.
[160] W. J. Boscardin,et al. Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction , 2009, Circulation. Cardiovascular interventions.
[161] E. Zakynthinos,et al. Inflammatory biomarkers in coronary artery disease. , 2009, Journal of cardiology.
[162] F. Van de Werf,et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. , 2009, European heart journal.
[163] Carl J Pepine,et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.
[164] Michael Höpfner,et al. Structural Adaptation and Heterogeneity of Normal and Tumor Microvascular Networks , 2009, PLoS Comput. Biol..
[165] A. Pries,et al. Origins of heterogeneity in tissue perfusion and metabolism. , 2009, Cardiovascular research.
[166] E. K. Weir,et al. The metabolic basis of vascular oxygen sensing: diversity, compartmentalization, and lessons from cancer. , 2008, American journal of physiology. Heart and circulatory physiology.
[167] R. Bache,et al. Regulation of coronary blood flow during exercise. , 2008, Physiological reviews.
[168] W. J. van der Giessen,et al. Functional and Structural Adaptations of Coronary Microvessels Distal to a Chronic Coronary Artery Stenosis , 2008, Circulation research.
[169] W. Guo,et al. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. , 2008, European heart journal.
[170] M. Marzilli. Coronary microcirculation : the new frontier in coronary artery disease , 2008 .
[171] Andre Terzic,et al. Defective Metabolic Signaling in Adenylate Kinase AK1 Gene Knock-out Hearts Compromises Post-ischemic Coronary Reflow* , 2007, Journal of Biological Chemistry.
[172] S. Gabriel,et al. C-reactive protein and heart failure after myocardial infarction in the community. , 2007, The American journal of medicine.
[173] F. Crea,et al. Coronary microvascular dysfunction. , 2013, The New England journal of medicine.
[174] M. Robson,et al. Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.
[175] B. Gersh,et al. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? , 2007, European heart journal.
[176] T. Rabelink,et al. Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.
[177] R. Bryan,et al. H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle. , 2007, American journal of physiology. Heart and circulatory physiology.
[178] A. Voss,et al. Detection of Coronary Microembolization by Doppler Ultrasound in Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Interventions , 2007, Circulation.
[179] R. Bryan,et al. H 2 O 2 activates redox-and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle , 2007 .
[180] J. Tune,et al. Hydrogen Peroxide: A Feed-Forward Dilator That Couples Myocardial Metabolism to Coronary Blood Flow , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[181] J. Tune. Withdrawal of vasoconstrictor influences in local metabolic coronary vasodilation. , 2006, American journal of physiology. Heart and circulatory physiology.
[182] J. Liao,et al. Physiological role of ROCKs in the cardiovascular system. , 2006, American journal of physiology. Cell physiology.
[183] Sujoy Khan. Acute oxygen-sensing mechanisms. , 2006, The New England journal of medicine.
[184] J. López-Barneo,et al. Acute oxygen-sensing mechanisms. , 2005, The New England journal of medicine.
[185] A. Voss,et al. Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions , 2005, Heart.
[186] F. Kajiya,et al. Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[187] S. Gupte,et al. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[188] F. Kajiya,et al. Coronary microcirculation: Physiology and mechanics , 2005 .
[189] P. Libby,et al. Pathophysiology of Coronary Artery Disease , 2005, Circulation.
[190] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[191] S. Archer,et al. Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. , 2004, Journal of molecular and cellular cardiology.
[192] G. Jackson. Endothelial function and dysfunction , 2004, International journal of clinical practice.
[193] A. Kirtane,et al. Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. , 2004, The American journal of cardiology.
[194] Deepak L. Bhatt,et al. Inflammation and atherosclerosis , 2004, Current atherosclerosis reports.
[195] K. Smith,et al. Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.
[196] A. Maseri. Mechanisms of myocardial ischemia , 1990, Cardiovascular Drugs and Therapy.
[197] Rodolphe Thiébaut,et al. Combination antiretroviral therapy and the risk of myocardial infarction , 2003 .
[198] I. Olivotto,et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[199] G. Heusch,et al. Serum but not myocardial TNF-alpha concentration is increased in pacing-induced heart failure in rabbits. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[200] Daniel Steinberg,et al. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime , 2002, Nature Medicine.
[201] P. Ridker,et al. Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.
[202] Toru Suzuki,et al. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. , 2002, Clinical biochemistry.
[203] T. Sawamura,et al. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. , 2002, Pharmacology & therapeutics.
[204] J. Mehta,et al. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. , 2002, Journal of the American College of Cardiology.
[205] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[206] Pepine,et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. , 2001, American heart journal.
[207] George A. Diamond,et al. Peripheral Arterial Responses to Treadmill Exercise Among Healthy Subjects and Atherosclerotic Patients , 2001, Circulation.
[208] T. Matsuo,et al. Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes , 2001, Circulation.
[209] P. Libby,et al. Inflammation and thrombosis: the clot thickens. , 2001, Circulation.
[210] E. Braunwald,et al. Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy , 2000, Circulation.
[211] M. Ellestad,et al. Prevalence of patent foramen ovale in patients with acute myocardial infarction and angiographically normal coronary arteries. , 2000, The American journal of cardiology.
[212] K. Shirato,et al. Coronary microcirculation: physiology and pharmacology. , 2000, Pharmacology & therapeutics.
[213] O. Hess,et al. alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans. , 2000, Circulation.
[214] D. Granger,et al. Pathophysiology of ischaemia–reperfusion injury , 2000, The Journal of pathology.
[215] A. Maseri,et al. The variable role of inflammation in acute coronary syndromes and in restenosis. , 1999, Seminars in interventional cardiology : SIIC.
[216] A. Maseri,et al. Pathogenic mechanisms in unstable angina , 1999, Heart.
[217] F. Burzotta,et al. Homocysteine and arterial occlusive disease: a concise review. , 1999, Cardiologia.
[218] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[219] G. Ottaviani,et al. Proliferating cell nuclear antigen (PCNA) and apoptosis in hyperacute and acute myocardial infarction. , 1999, European journal of histochemistry : EJH.
[220] C. Tiefenbacher,et al. Heterogeneity of coronary vasomotion , 1998, Basic Research in Cardiology.
[221] M. Lindsey,et al. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. , 1998, Circulation.
[222] E. Gurfinkel,et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.
[223] A. Camm,et al. Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction , 1997 .
[224] W. Chilian. Coronary microcirculation in health and disease. Summary of an NHLBI workshop. , 1997, Circulation.
[225] R. Bohle,et al. Tumor necrosis factor-α in macrophages of heart, liver, kidney, and in the pituitary gland , 1996, Cell and Tissue Research.
[226] J. Muller,et al. Triggering Myocardial Infarction by Sexual Activity: Low Absolute Risk and Prevention by Regular Physical Exertion , 1996 .
[227] J. Muller,et al. Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators. , 1996, JAMA.
[228] T. Paavonen,et al. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. , 1995, Circulation.
[229] A. Rebuzzi,et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.
[230] V. Fuster,et al. Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.
[231] J. Koyama,et al. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. , 1994, Journal of the American College of Cardiology.
[232] L. Opie,et al. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias , 1994, The Lancet.
[233] A. Becker,et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.
[234] J. Coligan,et al. Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. , 1993, Journal of immunology.
[235] J I Hoffman,et al. Pressure-flow relations in coronary circulation. , 1990, Physiological reviews.
[236] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[237] E. Feigl,et al. Coronary physiology. , 1983, Physiological reviews.
[238] T. M. James. Angina Without Coronary Disease (sic) , 1970, Circulation.
[239] M. Prinzmetal,et al. Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.